Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

Drygalski Krzysztof; Fereniec Eliza; Korycinski Krzysztof; Chomentowski Andrzej; Kielczewska Aleksandra; Odrzygozdz Cezary; Modzelewska Beata

首页> 外文期刊>Experimental Gerontology >Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

【24h】

Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

机译：白藜芦醇和阿尔茨海默病。从分子病理生理学到临床试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Experimental Gerontology》 |2018年第2018期|共12页
作者
Drygalski Krzysztof; Fereniec Eliza; Korycinski Krzysztof; Chomentowski Andrzej; Kielczewska Aleksandra; Odrzygozdz Cezary; Modzelewska Beata;
展开▼
作者单位

Med Univ Bialystok Dept Biophys Ul Mickiewicza 2A PL-15089 Bialystok Poland;

Nicolaus Copernicus Univ Torun Dept Clin Pathomorphol Coll Med Bydgoszcz Ul Curie Sklodowskiej 9;

Med Univ Bialystok Dept Biophys Ul Mickiewicza 2A PL-15089 Bialystok Poland;

Med Univ Bialystok Dept Biophys Ul Mickiewicza 2A PL-15089 Bialystok Poland;

Med Univ Bialystok Dept Biophys Ul Mickiewicza 2A PL-15089 Bialystok Poland;

Polish Acad Sci Inst Human Genet Dept Nucle Acid Funct Ul Strzeszynska 32 PL-60479 Poznan;

Med Univ Bialystok Dept Biophys Ul Mickiewicza 2A PL-15089 Bialystok Poland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类老年病学;
关键词

相似文献

外文文献
中文文献
专利

1. Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials [J] . Drygalski Krzysztof, Fereniec Eliza, Korycinski Krzysztof, Experimental Gerontology . 2018,第期

机译：白藜芦醇和阿尔茨海默病。从分子病理生理学到临床试验
2. Designing clinical trials to test disease-modifying agents: application to the treatment trials of Alzheimer's disease. [J] . Xiong C, van Belle G, Miller JP, Clinical trials: journal of the Society for Clinical Trials . 2011,第1期

机译：设计测试疾病改变剂的临床试验：在阿尔茨海默氏病治疗试验中的应用。
3. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease. [J] . Rockwood K, Fay S, Gorman M International journal of geriatric psychiatry . 2010,第2期

机译：加兰他敏治疗阿尔茨海默氏病的VISTA临床试验中的ADAS-cog和具有临床意义的变化。
4. Machine Learning classification of MRI features of Alzheimer's disease and mild cognitive impairment subjects to reduce the sample size in clinical trials [C] . Escudero Javier, Zajicek John P., Ifeachor Emmanuel 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2011

机译：针对阿尔茨海默氏病和轻度认知障碍受试者的MRI特征的机器学习分类，以减少临床试验中的样本量
5. Determinants of clinical progress in Alzheimer's disease. [D] . Lam, Chiu Wa. 2006

机译：阿尔茨海默氏病临床进展的决定因素。
6. Clinical trials in Alzheimers disease. A report from the Medical Research Council Alzheimers Disease Clinical Trials Committee. [O] . M Swash, D N Brooks, N E Day, 1991

机译：阿尔茨海默氏病的临床试验。医学研究委员会老年痴呆症临床试验委员会的报告。
7. Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee. [O] . Swash, M, Brooks, D N, Day, N E, 1991

机译：阿尔茨海默氏病的临床试验。医学研究委员会老年痴呆症临床试验委员会的报告。

Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

著录项

相似文献

相关主题

期刊订阅